These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 725135)
1. [Growth control of experimental tumour. I. Host protection against tumour by previous inoculation of plasmatic membrane of tumour cell (author's transl)]. Gomes RM; Preza PA; Bastos VC; Coelho MG; Kovary K; de Castro Faria H Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):229-35. PubMed ID: 725135 [TBL] [Abstract][Full Text] [Related]
2. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells. Lauro G; Businaro R; Butler RH; Revoltella R J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017 [TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro. Lynch DH; Gurish MF; Daynes RA Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587 [TBL] [Abstract][Full Text] [Related]
4. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice]. Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287 [TBL] [Abstract][Full Text] [Related]
6. Inhibition by lymphoid cellular factors of the immunological cytotoxicity against a syngeneic tumour. Lafontaine N; Firket H Pathol Eur; 1976; 11(2):147-50. PubMed ID: 958732 [TBL] [Abstract][Full Text] [Related]
7. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells. Cihak J; Ziegler HW; Kölsch E Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902 [TBL] [Abstract][Full Text] [Related]
8. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. Bright RK; Shearer MH; Kennedy RC J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411 [TBL] [Abstract][Full Text] [Related]
9. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system. Gjedde SB Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype. Ghosh SK; White LM; Ghosh R; Bankert RB J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719 [TBL] [Abstract][Full Text] [Related]
11. Immunologic studies of prostatic cancer using the R3327 rat model. Lubaroff DM; Reynolds CW; Culp DA Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024 [TBL] [Abstract][Full Text] [Related]
12. The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro. Farram E; Festenstein H; de Giorgi L Clin Exp Immunol; 1978 Sep; 33(3):377-85. PubMed ID: 737892 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development. Bright RK; Shearer MH; Pass HI; Kennedy RC Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255 [TBL] [Abstract][Full Text] [Related]
14. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
15. [Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)]. Favre R; Filipczyk J; Berebbi M; Meyer G Ann Immunol (Paris); 1974; 125(3):491-7. PubMed ID: 4369657 [No Abstract] [Full Text] [Related]
16. [Inflammation and host resistance against tumours. I. Delayed growth of Lewis tumour and inhibition of lung metastasis in mice having an inflammatory reaction distant from the inoculation site of tumour cells (author's transl)]. Fauve RM; Hevin MB Ann Immunol (Paris); 1977; 128C(4-5):923-8. PubMed ID: 900902 [TBL] [Abstract][Full Text] [Related]
17. Antitumor resistance formation in animals in early neonatal period. Kazmin SD; Todor IN; Chekhun VE J Exp Clin Cancer Res; 2007 Mar; 26(1):83-90. PubMed ID: 17550136 [TBL] [Abstract][Full Text] [Related]
18. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures. Hurrell SM; Zarling JM J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084 [TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade. Hines DL Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516 [TBL] [Abstract][Full Text] [Related]
20. Host responses in adjuvant contact suppression of experimental rat tumours. Pimm MV; Hopper DG; Baldwin RW Dev Biol Stand; 1977 Apr 13-15; 38():349-54. PubMed ID: 344098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]